Stifel Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Raises Target Price to $494

Futu News58minutes ago · Ratings

Stifel Adjusts Price Target on Vertex Pharmaceuticals to $494 From $490, Maintains Hold Rating

MT Newswires19:34 · Ratings

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

BenzingaDec 13 23:45

TD Cowen Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $525

Futu NewsDec 12 19:33 · Ratings

TD Cowen Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TipRanksDec 12 18:45

Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks Dec 11 06:05